Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2010
11/04/2010US20100278845 Melanocortin Receptor Binding Conjugates
11/04/2010US20100278839 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278834 Antibodies against h5n1 strains of influenza a virus
11/04/2010US20100278832 Anti-bst2 antibody
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278823 Treatment of type 1 diabetes before and after expression of predisposition markers
11/04/2010US20100278821 N-cadherin: target for cancer diagnosis and therapy
11/04/2010US20100278820 Reagents that bind ccx-ckr2
11/04/2010US20100278819 Streptococcus pneumoniae vaccines
11/04/2010US20100278818 Antibody specific for the Tn antigen for the treatment of cancer
11/04/2010US20100278816 B7-dc binding antibody
11/04/2010US20100278814 Prevention and treatment of synucleinopathic and amyloidogenic disease
11/04/2010US20100278813 Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
11/04/2010US20100278809 Inhibitors of MRP4 for the Treatment of Vascular Disorders
11/04/2010US20100278808 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
11/04/2010US20100278750 Polylysine dendrimer contrast agent
11/04/2010US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules
11/04/2010US20100278736 FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
11/04/2010US20100278729 Breast cancer eradication program
11/04/2010US20100278728 Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
11/04/2010CA2764432A1 Anti-il-3ra antibody for use in treatment of blood tumor
11/04/2010CA2760642A1 Anti-cadherin antibody
11/04/2010CA2760553A1 Monoclonal antibodies to influenza h1n1 virus and uses thereof
11/04/2010CA2760542A1 A non-target amplification method for detection of rna splice-forms in a sample
11/04/2010CA2760525A1 Toll-like receptor 3 antagonists
11/04/2010CA2760385A1 Anti ceacam1 antibodies and methods of using same
11/04/2010CA2760332A1 Dual variable domain immunoglobulins and uses thereof
11/04/2010CA2760330A1 Dc-stamp antibodies
11/04/2010CA2760213A1 Dual variable domain immunoglobulins and uses thereof
11/04/2010CA2760096A1 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
11/04/2010CA2759989A1 Anti cxcr4 antibodies for the treatment of hiv
11/04/2010CA2759797A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
11/04/2010CA2759792A1 Improved antibodies immunoreactive with heregulin-coupled her3
11/04/2010CA2759502A1 Purification of immunoconjugates
11/04/2010CA2759370A1 Method for the production of domain antibodies
11/04/2010CA2758290A1 Antagonistic activin receptor iib (actriib)antibodies for increasing muscle growth
11/04/2010CA2757638A1 Erg monoclonal antibodies
11/04/2010CA2756760A1 Compositions and methods for screening and using compounds antagonizing spore-surface interactions
11/03/2010EP2246703A1 Salvinorin Immunoassay
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246427A1 Antibody capable of binding specifically to a -oligomer, and use thereof
11/03/2010EP2246426A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody
11/03/2010EP2246364A1 Anti CXCR4 antibodies for the treatment of HIV
11/03/2010EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
11/03/2010EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2010EP2246342A2 Triacetone triperoxide and diacetone diperoxide derivative, method for their manufacture and their application
11/03/2010EP2246070A2 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b
11/03/2010EP2245156A1 Humanized anti- 9 integrin antibodies and the uses thereof
11/03/2010EP2245150A1 Protease for wound conditioning and skin care
11/03/2010EP2245071A1 1d05 pcsk9 antagonists
11/03/2010EP2245070A1 1b20 pcsk9 antagonists
11/03/2010EP2245069A1 Humanized antibodies specific for von willebrand factor
11/03/2010EP2245068A1 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
11/03/2010EP2245067A2 Methods of using cadherin 11 (cdh11) antagonists
11/03/2010EP2245066A2 Ron antibodies and uses thereof
11/03/2010EP2245065A1 Optimized cd40 antibodies and methods of using the same
11/03/2010EP2245064A2 Binding members for interleukin-4 receptor alpha (il-4r ) - 173
11/03/2010EP2245063A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
11/03/2010EP2245062A1 Methods of treating bone-loss disorders using a gm-csf antagonist
11/03/2010EP2245061A2 Impaired wound healing compositions and treatments
11/03/2010EP2245052A2 Selective exosite inhibition of papp-a activity against igfbp-4
11/03/2010EP2245049A2 Vaccines and diagnostics for the ehrlichioses
11/03/2010EP2244736A1 Ligands of the natural killer (nk) cell surface marker cd27 and therapeutic uses thereof
11/03/2010EP2244729A1 Cysteine engineered antibodies for site-specific conjugation
11/03/2010EP2244723A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation
11/03/2010EP2244720A2 Polypeptide vaccine and vaccination strategy against mycobacterium
11/03/2010EP1712626B1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1674111B1 Anti-glypican 3 antibody
11/03/2010EP1546205B1 Methods for regulating cancer
11/03/2010EP0912734B1 Chimeric heteromultimer adhesins
11/03/2010EP0568575B2 Test and model for alzheimer's disease
11/03/2010CN1551783B Use of analog K121 antibody in preparing medicine for K type multiple myeloma
11/03/2010CN1368888B Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease
11/03/2010CN101878302A Pseudomonas aeruginosa outer membrane protein PA4710
11/03/2010CN101878301A Antibody and use thereof
11/03/2010CN101878229A Immunoliposomes for treatment of cancer
11/03/2010CN101878228A Human monoclonal nicotine specific antibodies
11/03/2010CN101878227A Monomeric vhh domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
11/03/2010CN101878224A Erythropoietin
11/03/2010CN101875697A Design of novel anti-EGFR humanized antibody TGM10 and application thereof
11/03/2010CN101875696A Antibody, and preparation method and application thereof
11/03/2010CN101875695A Antibody, and coding gene and application thereof
11/03/2010CN101875694A Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof
11/03/2010CN101875689A New gene for rice zinc-finger protein transcription factor and application thereof to drought resistance and salt tolerance
11/03/2010CN101014619B Optimized fc variants
11/02/2010US7825292 Hamster model comprising muscle protein mutation for use in treatment and prevention of cardiovascular disorders
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825225 Vaccine
11/02/2010US7825224 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression
11/02/2010US7825223 Purification of antibody from cell culture for use in treatment of Alzheimer's
11/02/2010US7825222 Therapeutic binding molecules
11/02/2010US7825220 Growth suppressor protein-1 (Gros1) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7824876 Method for diagnosing acute coronary syndrome
11/02/2010US7824865 Method for examining WT1-related disease
1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 1494